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Introduction: Gestational diabetes mellitus (GDM) is a glucose metabolism disorder of various 
degrees which occurs in pregnancy and resolves spontaneously in the puerperium. Due to the 
adverse effects of GDM on pregnancy outcomes, perinatal morbidity, and the development of 
chronic diseases later in life, increased attention is given to GDM. 
 
Aim of the thesis: The aim of this thesis was the provide a basic overview of the types of 
diabetes mellitus together with a description of metabolic processes and some selected 
biomarkers, with the main focus on GDM. Another aim was to evaluate the consequences and 
assess the impact of selected parameters on the onset and development of GDM, changes in 
the monitored values during pregnancy and the consequences for mother and fetus. 
 
Methods: The research subjects were 110 pregnant women diagnosed with GDM at the 
Diabetological Clinic of the 3rd Department of Internal Medicine-Metabolic Care and 
Gerontology of University Hospital Hradec Králové and subsequently at the Department of 
Obstetrics and Gynecology from November 1, 2019, to September 11, 2020. GDM was 
diagnosed in 23 women in the screening phase I (11-14 weeks of pregnancy) and in 87 women 
in the screening phase II (24-28 weeks of pregnancy).We monitored and statistically processed 
the following parameters and values: patient age, height, pre-pregnancy weight, pre-
pregnancy BMI, pre-delivery weight, pre-delivery BMI, weight gain during pregnancy, glycemic 
values, glycated hemoglobin (HbA1C), thyrotropin (TSH) and free thyroxine (T4V), therapy 
(diet, metformin, insulin), gestational age of the patient, method of termination of labor, 
complications during childbirth, neonatal weight and apgar score. 
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Results: In the theoretical part of the thesis, we focused on the issue of diabetes mellitus. We 
have described GDM in terms of historical, epidemiological, physiological, pathological, 
pharmacological, and clinical aspects. We also focused on the description of factors that 
accompany / predict insulin resistance in GDM. 
In our research, a higher average age was found in women with a GDM diagnosis in the 
screening phase II. Values such weight before pregnancy and before childbirth, T4V and 
gestational age were lower in women diagnosed in the screening phase II, but HbA1C and TSH 
levels were higher compared to women diagnosed in the screening phase I. 
The diagnosis of GDM in the screening phase I was established according to the WHO 
guideline based on two abnormal fasting blood glucose values (values did not exceed 6.4 
mmol/l) or oral glucose tolerance test (oGTT). The abnormal blood glucose readings were 
found 120 minutes after administering a 75-g glucose solution to the subjects. The same 
applied to women diagnosed in the screening phase II. A statistically significant positive effect 
(p < 0.001) between glycemia and factors associated with childbirth and the postpartum 
period was found. 13.0 % of women GDM diagnosed in the screening phase I underwent a 
caesarean delivery and 87.0 % a vaginal delivery, with the most common complications being 
a perineal tear (21.7 %), episiotomy (17.4 %) and vaginal injuries (17.4 %). 26.4 % of women 
diagnosed in the screening phase II underwent a caesarean section and 73.6 % a vaginal 
delivery, with episiotomy (31.0 %) as the most common complication. A (suspect) 
exacerbation after childbirth was observed only in 5 (4.5 %) of all women monitored. A 
statistically significant relationship was demonstrated between complications during 
childbirth and the postpartum condition (p < 0.001). 
In our study, macrosomia occurred in 4 children (17.4 %) of women diagnosed in the 
screening phase I and 9 children (10.3 %) of women diagnosed in the screening phase II. Higher 
neonatal weight had a statistically significant relationship with increasing BMI before 
pregnancy (p = 0.007), increasing gestational age (p < 0.001) and insulin treatment (p = 0.027). 
We also found that with increasing age, pregnancy weight gain was lower in women diagnosed 
with GDM (p = 0.008). In our study, 99.09 % of women maintained their weight gain relative 
to their pre-pregnancy BMI in the optimal range. The most women diagnosed in the screening 
phase I (25.0 %) had class III obesity (BMI ≥ 40.0) and the most women diagnosed in the 
screening phase II (33.0 %) were overweight (BMI 25.0-29.99). 
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A significant difference was found in T4V (µmol/l) (p = 0.01) and insulin treatment (p = 
0.017). In women diagnosed in the screening phase I, insulin was prescribed more frequently 
and the T4V levels was higher. As GDM treatment, dietary management was sufficient in up 
to 48.0 % of subjects diagnosed in the screening phase I, 26.09 % of subjects administered 
insulin and 26.09 % used metformin. In 85.0% of women diagnosed in the screening phase II, 
compensation was reached by dietary management, 9.0 % had to use insulin and 6.0 % 
metformin. 
The research found a correlation between the mother’s prepartum BMI and the birth 
weight of the child (k = 0.302), gestational age and birth weight of the child (k = 0.522), 
prepartum BMI and insulin treatment (k = 0.394) and prepartum BMI and insulin treatment (k 
= 0.397). The results also demonstrated a positive correlation between gestational age and 
the apgar score (k = 0.222). 
 
Conclusion: The incidence of glucose metabolism disorders in pregnancy is increasing and is 
associated with obesity and overweight of women in the population. The prevalence in the 
Czech Republic varies between 1-14 %. It is an asymptomatic disease. The results support the 
need to actively approach the search for asymptomatic cases in clinical practice and 
emphasize the careful education of pregnant women, since decompensated diabetes carries 
risks for the mother and fetus during pregnancy and after childbirth. 
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